Sanofi Contingent Value Rights
GCVRZ
GCVRZ was delisted on the 3rd of March, 2020.
146 hedge funds and large institutions have $324M invested in Sanofi Contingent Value Rights in 2013 Q2 according to their latest regulatory filings, with 146 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
Top Sellers
GCVRZ Hedge Fund Activity: Q2 2013 in Review
146 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q2 2013, worth a combined $324M.
Buyers outnumbered sellers: 146 funds opened new GCVRZ positions and 0 closed out — a net gain of 146 holders — while 0 added to existing stakes and 0 trimmed.
- 146 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $324M of Sanofi Contingent Value Rights stock for Q2 2013.
- 146 funds opened new Sanofi Contingent Value Rights positions in Q2 2013 and 0 closed out, a net change of +146 holders.
Based on aggregated 13F filings for Q2 2013.